Tempong, Jerome F.

HRN: 05-27-54  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2024
CEFTRIAXONE 1G (VIAL)
03/01/2024
03/07/2024
IV
2g
Q 24H
Severe TBI, Multiple Soft Tissue Injuries Head And Extremities
Waiting Final Action 
03/07/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/07/2024
03/20/2024
IVT
4.5g
Q8
Severe TBI; Multiple Soft Tissue Injuries Head And Extremities
Waiting Final Action 
03/12/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/11/2024
03/17/2024
IVT
500mg
OD
CAP MR; S/p Tracheostomy
Waiting Final Action 
03/12/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/11/2024
03/17/2024
IVT
500mg
OD
CAP HR; S/p Tracheostomy
Waiting Final Action 
03/29/2024
CEFTAZIDIME 1GM (VIAL)
03/29/2024
04/04/2024
IV
1gm
Q8
Septicemia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: